Alpa Laboratories Limited

108.54

INR
+0.41(+0.38%)
As of November 14, 2024 10:00:00 AM

Alpa Laboratories Limited Share Price Information

24 hour Low and High

Low: 105.6
High: 109.3

All time High

139.20

Price Change 1h

+₹-0.76 +-0.70%

Price Change 1d

+₹-0.76 +-0.70%

Price Change 1w

+₹-4.23 +-3.75%

Alpa Laboratories Limited Market Information

Exchange

NSE

Market Cap

235.27 Cr

About Alpa Laboratories Limited Share

Alpa Laboratories Limited engages in the manufacture and sale of pharmaceutical finished dosage forms in India. The company offers ethical, generic, and over the counter pharmaceutical products in various finished dosage forms, including injections, tablets, capsules, eye and ear drops, creams, gels, and ointments for human and veterinary use. It also provides drugs in various categories, such as anti-infectives comprising antibacterial, antibiotics, antifungals, antiprotozoals, and antivirals; analgesics; anti-inflammatory drugs; cough and cold drugs; cardiovascular drugs; anti-diabetics; nutritional supplements; psychotropic drugs; and skin care preparations, as well as ear and eye care preparations. The company sells its products through distributors, retail chemists, retail pharmacy stores, and hospitals. It also exports its products to South and Central America, Africa, and Asia, Russia, Ukraine, Kazakhstan, and internationally. The company was founded in 1967 and is based in Indore, India.

Sector

Healthcare

Drug Manufacturers - Specialty & Generic

Employees

about

410

CEO

Revenue (2023)

%

Country of Origin

India

Key Highlights

  • Alpa Laboratories consolidated net profit rises 32.82% in the September 2024 quarter
  • Alpa Laboratories' Stock Reaches All-Time High, Outperforms Sector by 2.14%
  • Alpa Laboratories Ltd leads gainers in 'B' group
  • Increases to Alpa Laboratories Limited's (NSE:ALPA) CEO Compensation Might Cool off for now
  • Alpa Laboratories Ltd leads gainers in 'B' group

FAQs

Alpa Laboratories Limited

108.54

INR
+0.41(+0.38%)
As of November 14, 2024 10:00:00 AM

Alpa Laboratories Limited Share Price Information

24 hour Low and High

Low: 105.6
High: 109.3

All time High

139.20

Price Change 1h

+₹-0.76 +-0.70%

Price Change 1d

+₹-0.76 +-0.70%

Price Change 1w

+₹-4.23 +-3.75%

Alpa Laboratories Limited Market Information

Exchange

NSE

Market Cap

235.27 Cr

About Alpa Laboratories Limited Share

Alpa Laboratories Limited engages in the manufacture and sale of pharmaceutical finished dosage forms in India. The company offers ethical, generic, and over the counter pharmaceutical products in various finished dosage forms, including injections, tablets, capsules, eye and ear drops, creams, gels, and ointments for human and veterinary use. It also provides drugs in various categories, such as anti-infectives comprising antibacterial, antibiotics, antifungals, antiprotozoals, and antivirals; analgesics; anti-inflammatory drugs; cough and cold drugs; cardiovascular drugs; anti-diabetics; nutritional supplements; psychotropic drugs; and skin care preparations, as well as ear and eye care preparations. The company sells its products through distributors, retail chemists, retail pharmacy stores, and hospitals. It also exports its products to South and Central America, Africa, and Asia, Russia, Ukraine, Kazakhstan, and internationally. The company was founded in 1967 and is based in Indore, India.

Sector

Healthcare

Drug Manufacturers - Specialty & Generic

Employees

about

410

CEO

Revenue (2023)

%

Country of Origin

India

Key Highlights

  • Alpa Laboratories consolidated net profit rises 32.82% in the September 2024 quarter
  • Alpa Laboratories' Stock Reaches All-Time High, Outperforms Sector by 2.14%
  • Alpa Laboratories Ltd leads gainers in 'B' group
  • Increases to Alpa Laboratories Limited's (NSE:ALPA) CEO Compensation Might Cool off for now
  • Alpa Laboratories Ltd leads gainers in 'B' group

FAQs